Alpha Optical Inc. Eyewear Supplier (Equipment, not the service) Location: 319 Main St, Emmaus, Pennsylvania 18049 Phone: (610) 421-8495 |
Art Schneck Optical Co. Medicare Supplier Location: 720 Harrison St, Emmaus, Pennsylvania 18049 Phone: (610) 965-4066 |
Cvs Pharmacy # 01178 Durable Medical Equipment & Medical Supplies Location: 702 Chestnut Street, Emmaus, Pennsylvania 18049 Phone: (610) 965-5980 |
The Breastfeeding Shop Medicare Supplier Location: 308 Main St, Emmaus, Pennsylvania 18049 Phone: (866) 255-6779 |
Rite Aid Pharmacy #11046 Durable Medical Equipment & Medical Supplies Location: 1328 Chestnut St, Emmaus, Pennsylvania 18049 Phone: (610) 967-6440 |
Weis Pharmacy #76 Pharmacy Location: 1220 Chestnut St, Emmaus, Pennsylvania 18049 Phone: (610) 967-2900 |
News Archive
Student loans aren't the only reason young adults end up in debt. One of the largest-ever studies of work-related risks in young adult cancer survivors finds that of 872 survivors, 14.4 percent borrowed more than $10,000 and 1.5 percent said they or their family had filed for bankruptcy as a direct result of illness or treatment.
Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134 000 lives saved through the implementation of a two-year response plan, published/launched today by the World Health Organization (WHO) and the Stop TB Partnership.
Food insecurity affects nearly 795 million people worldwide. Although a complex phenomenon encompassing food availability, affordability, utilization, and even the social norms that define acceptable ways to acquire food, FI can affect people's health beyond its impact on nutrition.
In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others.
Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.
› Verified 8 days ago